ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway
Source: SeekingAlpha
2026-02-25 18:28:29 ET
More on ADMA Biologics
- ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
- ADMA Biologics: Business Update And My Price Target
- ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ADMA Biologics GAAP EPS of $0.20 beats by $0.02, revenue of $139.16M misses by $0.64M
- ADMA Biologics reports FY 2025 revenue in line with estimate, provides 2026–2029 outlook
Read the full article on Seeking Alpha
For further details see:
ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway
ADMA Biologics Inc
NASDAQ: ADMA
ADMA Trading
2.36% G/L:
$16.025 Last:
547,760 Volume:
$15.69 Open:
ADMA Latest News
March 02, 2026 07:00:00 am
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
February 25, 2026 04:05:00 pm
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 18, 2026 07:00:00 am
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
ADMA Stock Data
$3,926,963,123
229,191,848
0.3%
148
N/A
Biotechnology & Life Sciences
Healthcare
US
Ramsey
